TELA Bio (TELA) EBIT Margin Growth (3y) (2021 - 2026)
TELA Bio (TELA) EBIT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 244.00 |
| 10 | TELA Bio | 37.05 Mn | 6.63 Mn | 13.94 Mn | 2,337.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,337.00 |
| Mar 31, 2026 | 3,927.00 |
| Dec 31, 2025 | 4,936.00 |
| Sep 30, 2025 | 4,850.00 |
| Jun 30, 2025 | 5,341.00 |
| Mar 31, 2025 | 6,305.00 |
| Dec 31, 2024 | 4,407.00 |
| Sep 30, 2024 | 4,489.00 |
| Jun 30, 2024 | 2,483.00 |
| Mar 31, 2024 | 9,462.00 |
| Dec 31, 2023 | 4,683.00 |
| Sep 30, 2023 | 6,153.00 |
| Jun 30, 2023 | 7,581.00 |
| Mar 31, 2023 | 7,992.00 |
| Dec 31, 2022 | 3,856.00 |
| Sep 30, 2022 | 1,204.00 |
| Jun 30, 2022 | 3,181.00 |
| Mar 31, 2022 | 3,709.00 |
| Dec 31, 2021 | 13,513.00 |
| Sep 30, 2021 | 1,981.00 |